Lanker Klossner B, Widmer H R, Frey F
Department of Internal Medicine, Nephrology, University Hospital of Berne, Switzerland.
Dermatology. 1997;195 Suppl 2:10-3. doi: 10.1159/000246024.
Since the bacterial ability to develop resistance against various factors of their surroundings is a well-known phenomenon, resistance against iodine and specifically against povidone-iodine (PVP-I) has been widely investigated. Yet there is little known about bacterial resistance in long-term daily use of disinfectants in continuous ambulatory peritoneal dialysis (CAPD) patients. The aim of our study was to investigate whether on daily use of PVP-I over a period of at least 6 months coagulase-negative staphylococci (CNS)--the predominant infective organisms of peritonitis--developed resistance against PVP-I. At the catheter exit site of 40 CAPD patients we isolated 36 CNS. 23 CNS (CNS + PVP) orginate from patients using PVP-I, 13 CNS (CNS + CI) from patients using sodium hypochlorite (NaOCl) as disinfectant. The strains were biotyped, antibiotic resistance patterns were determined and resistance against PVP-I or NaOCl was calculated as reduction factor using the quantitative suspension test combined with a turbidimetric standardization. Resistance against PVP-I 0.01% and against NaOCl 0.005% was determined at two contact times (30 and 300 s) for each patient group. In addition, we investigated the effects of plasmid loss on sensitivity to PVP-I. Out of 5 multiple-antibiotic-resistant CNS, 3 strains showed no difference in reduction factor against PVP-I before and after curing. There was no significant difference in reduction factor against NaOCl. CNS + PVP were even significantly more sensitive to PVP-I than CNS + Cl. Taken together, our results demonstrate that long-term use of PVP-I does not cause any bacterial resistance in CNS of CAPD patients.
由于细菌对周围环境各种因素产生耐药性的能力是一种众所周知的现象,因此对碘尤其是对聚维酮碘(PVP-I)的耐药性已得到广泛研究。然而,对于持续性非卧床腹膜透析(CAPD)患者长期每日使用消毒剂时的细菌耐药性却知之甚少。我们研究的目的是调查在至少6个月的时间里每日使用PVP-I是否会使凝固酶阴性葡萄球菌(CNS)——腹膜炎的主要感染病原体——对PVP-I产生耐药性。在40例CAPD患者的导管出口部位,我们分离出36株CNS。23株CNS(CNS + PVP)来自使用PVP-I的患者,13株CNS(CNS + CI)来自使用次氯酸钠(NaOCl)作为消毒剂的患者。对菌株进行生物分型,确定抗生素耐药模式,并使用定量悬液试验结合比浊标准化,将对PVP-I或NaOCl的耐药性计算为降低因子。在两个接触时间(30秒和300秒)测定每个患者组对0.01% PVP-I和0.005% NaOCl的耐药性。此外,我们研究了质粒丢失对PVP-I敏感性的影响。在5株多重耐药CNS中,3株菌株在治愈前后对PVP-I的降低因子没有差异。对NaOCl的降低因子没有显著差异。CNS + PVP对PVP-I的敏感性甚至比CNS + Cl显著更高。综上所述,我们的结果表明,长期使用PVP-I不会导致CAPD患者的CNS产生任何细菌耐药性。